No Data
No Data
J.P. Morgan's Top Healthcare Stocks for 2025
Express News | PTC Therapeutics Inc: PTC's Fourth Approval Application Submitted to FDA in 2024
Express News | PTC Therapeutics Announces Vatiquinone Nda Submission to FDA for the Treatment of Children and Adults Living With Friedreich Ataxia
PTC Therapeutics Announces Vatiquinone NDA Submission to FDA for the Treatment of Children and Adults Living With Friedreich Ataxia
Express News | PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Unlock the Full List